Q2 2024 |
46 |
$4.72B |
+$916M |
-$1.15B |
-$231M |
THC, CVS, CI, GPN, CTVA
|
13F-HR |
8/14/2024, 04:09 PM |
Q1 2024 |
43 |
$5.13B |
+$998M |
-$786M |
+$213M |
THC, CI, CTVA, UHS, GPN
|
13F-HR |
5/15/2024, 04:23 PM |
Q4 2023 |
41 |
$4.29B |
+$805M |
-$699M |
+$105M |
CI, THC, DXC, UHS, GPN
|
13F-HR |
2/14/2024, 04:26 PM |
Q3 2023 |
47 |
$3.68B |
+$779M |
-$496M |
+$284M |
THC, CI, UHS, GPN, DXC
|
13F-HR |
11/14/2023, 04:30 PM |
Q2 2023 |
46 |
$3.72B |
+$343M |
-$1.14B |
-$793M |
CI, THC, DXC, UHS, GPN
|
13F-HR |
8/14/2023, 04:13 PM |
Q1 2023 |
53 |
$4.07B |
+$549M |
-$773M |
-$224M |
CI, THC, FI, GPN, DXC
|
13F-HR |
5/15/2023, 04:18 PM |
Q4 2022 |
51 |
$4.17B |
+$637M |
-$752M |
-$116M |
CI, THC, DXC, FI, MCK
|
13F-HR |
2/14/2023, 04:21 PM |
Q3 2022 |
53 |
$3.94B |
+$667M |
-$556M |
+$111M |
CI, THC, FI, DXC, GPN
|
13F-HR |
11/14/2022, 04:12 PM |
Q2 2022 |
53 |
$3.93B |
+$649M |
-$806M |
-$158M |
CI, THC, GPN, DXC, MCK
|
13F-HR |
8/11/2022, 04:15 PM |
Q1 2022 |
58 |
$4.9B |
+$1.08B |
-$848M |
+$228M |
THC, CI, GPN, MCK, DXC
|
13F-HR |
5/16/2022, 04:43 PM |
Q4 2021 |
54 |
$4.61B |
+$379M |
-$1.6B |
-$1.22B |
THC, MCK, BHC, GPN, CI
|
13F-HR |
2/14/2022, 05:05 PM |
Q3 2021 |
2 |
$55.1M |
$0 |
$0 |
|
QSI, EVLV
|
New Holdings |
2/18/2022, 05:16 PM |
Q3 2021 |
60 |
$5.48B |
+$738M |
-$1B |
-$264M |
THC, BHC, MCK, CI, COR
|
13F-HR |
11/15/2021, 04:38 PM |
Q2 2021 |
65 |
$6.05B |
+$1.24B |
-$1.45B |
-$209M |
THC, BHC, CI, MCK, DXC
|
Restatement |
2/18/2022, 05:16 PM |
Q1 2021 |
63 |
$5.9B |
+$1.79B |
-$1.02B |
+$771M |
THC, BHC, CI, MCK, DXC
|
13F-HR |
5/17/2021, 04:06 PM |
Q4 2020 |
54 |
$4.28B |
+$638M |
-$498M |
+$141M |
THC, BHC, TAK, DXC, CI
|
13F-HR |
2/16/2021, 04:16 PM |
Q3 2020 |
45 |
$3.19B |
+$122M |
-$858M |
-$736M |
THC, TAK, BHC, CI, HCA
|
13F-HR |
11/16/2020, 04:09 PM |
Q2 2020 |
43 |
$3.62B |
+$508M |
-$1.37B |
-$865M |
THC, TAK, BHC, CI, HCA
|
13F-HR |
8/14/2020, 04:06 PM |
Q1 2020 |
44 |
$3.68B |
+$239M |
-$4.8B |
-$4.56B |
TAK, THC, CI, BHC, HCA
|
13F-HR |
5/15/2020, 04:07 PM |
Q4 2019 |
50 |
$11.4B |
+$2.01B |
-$1.9B |
+$109M |
HCA, CI, THC, PARA, TAK
|
13F-HR |
2/14/2020, 04:18 PM |
Q3 2019 |
49 |
$9.51B |
+$1.05B |
-$2.04B |
-$991M |
CI, HCA, MCK, IQV, TAK
|
13F-HR |
11/14/2019, 04:07 PM |
Q2 2019 |
46 |
$11B |
+$1.08B |
-$1.19B |
-$104M |
CI, HCA, IQV, FMC, MCK
|
13F-HR |
8/14/2019, 04:07 PM |
Q1 2019 |
45 |
$11.2B |
+$2.93B |
-$3.35B |
-$421M |
DXC, FMC, CI, MCK, IQV
|
13F-HR |
5/15/2019, 04:06 PM |
Q4 2018 |
48 |
$10.3B |
+$1.82B |
-$4.74B |
-$2.92B |
SHPG, FMC, IQV, HCA, CVS
|
13F-HR |
2/14/2019, 04:12 PM |
Q3 2018 |
57 |
$15.7B |
+$1.93B |
-$2.14B |
-$204M |
ESRX, FMC, AET, IQV, MCK
|
13F-HR |
11/14/2018, 04:09 PM |
Q2 2018 |
50 |
$14.7B |
+$936M |
-$3.83B |
-$2.89B |
SHPG, DWDP, FMC, MCK, THC
|
13F-HR |
8/14/2018, 04:08 PM |
Q1 2018 |
53 |
$17.1B |
+$1.97B |
-$2.65B |
-$680M |
HCA, SHPG, DWDP, FMC, IQV
|
13F-HR |
5/15/2018, 04:07 PM |
Q4 2017 |
58 |
$18.5B |
+$4.5B |
-$4.06B |
+$431M |
HCA, DWDP, FMC, SHPG, IQV
|
13F-HR |
2/14/2018, 04:26 PM |
Q3 2017 |
56 |
$17.2B |
+$3.5B |
-$2.27B |
+$1.23B |
HCA, DWDP, FMC, SHPG, Q
|
13F-HR |
11/14/2017, 04:18 PM |
Q2 2017 |
52 |
$15.4B |
+$2.67B |
-$3.05B |
-$378M |
HCA, FMC, DOW, Q, ELV
|
13F-HR |
8/14/2017, 04:26 PM |
Q1 2017 |
51 |
$15.1B |
+$1.36B |
-$2.55B |
-$1.19B |
HCA, HUM, ELV, DOW, FMC
|
13F-HR |
5/15/2017, 04:23 PM |
Q4 2016 |
48 |
$14.8B |
+$2.78B |
-$2.33B |
+$449M |
HCA, HUM, ELV, CI, AET
|
13F-HR |
2/14/2017, 04:25 PM |
Q3 2016 |
50 |
$14B |
+$2.14B |
-$2.74B |
-$608M |
HUM, HCA, CI, CBS, ELV
|
13F-HR |
11/14/2016, 04:20 PM |
Q2 2016 |
47 |
$14.1B |
+$1.7B |
-$1.55B |
+$147M |
HUM, HCA, MON, CI, ABBV
|
13F-HR |
8/15/2016, 04:10 PM |
Q1 2016 |
45 |
$13.7B |
+$478M |
-$4.24B |
-$3.76B |
HUM, HCA, MON, CI, ABBV
|
13F-HR |
5/16/2016, 04:11 PM |
Q4 2015 |
55 |
$17.8B |
+$2.84B |
-$5.44B |
-$2.6B |
HUM, MON, CI, HCA, TMO
|
13F-HR |
2/16/2016, 04:52 PM |
Q3 2015 |
78 |
$20.2B |
+$2.25B |
-$3.66B |
-$1.41B |
HUM, MON, TMO, ABBV, FLEX
|
13F-HR |
11/16/2015, 04:11 PM |
Q2 2015 |
81 |
$25.3B |
+$6.56B |
-$3.56B |
+$3B |
HUM, TMO, ABBV, MON, THC
|
13F-HR |
8/14/2015, 04:11 PM |
Q1 2015 |
80 |
$21.9B |
+$4.2B |
-$2.91B |
+$1.29B |
MON, FLEX, TMO, HUM, ELV
|
13F-HR |
5/15/2015, 04:18 PM |
Q4 2014 |
74 |
$20B |
+$3.14B |
-$3.31B |
-$169M |
TMO, MON, FLEX, THC, CYH
|
13F-HR |
2/17/2015, 04:13 PM |
Q3 2014 |
74 |
$19.1B |
+$4.14B |
-$2.42B |
+$1.72B |
TMO, MON, THC, FLEX, HCA
|
13F-HR |
11/14/2014, 04:09 PM |
Q2 2014 |
68 |
$17.2B |
+$3.76B |
-$2.51B |
+$1.25B |
TMO, MON, FLEX, HCA, THC
|
13F-HR |
8/14/2014, 04:14 PM |
Q1 2014 |
65 |
$15.1B |
+$4.18B |
-$2.55B |
+$1.63B |
TMO, MON, HCA, CCI, THC
|
13F-HR |
5/15/2014, 04:10 PM |
Q4 2013 |
60 |
$13.2B |
$0 |
$0 |
|
TMO, HCA, THC, MON, CCI
|
13F-HR |
2/14/2014, 04:20 PM |